Covalon Technologies PE Ratio 2013-2024 | CVALF

Current and historical p/e ratio for Covalon Technologies (CVALF) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Covalon Technologies PE ratio as of December 02, 2024 is 0.00.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

Covalon Technologies PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
0.00 nan
Sector Industry Market Cap Revenue
Medical Medical Instruments Manufacturing $0.073B $0.020B
Covalon Technologies Ltd. researches, develops and commercializes new healthcare technologies. The company's patented technologies, product and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Its technologies are used to prevent, detect and manage medical conditions in specialty areas such as infection control, vascular access, surgical procedures, advanced wound care and medical device coatings. Covalon Technologies Ltd. is based in Mississauga, Canada.
Stock Name Country Market Cap PE Ratio
Thermo Fisher Scientific (TMO) United States $202.706B 24.73
Intuitive Surgical (ISRG) United States $193.352B 101.09
Alcon (ALC) Switzerland $43.519B 29.12
Edwards Lifesciences (EW) United States $41.599B 26.42
IQVIA Holdings (IQV) United States $36.625B 20.18
IDEXX Laboratories (IDXX) United States $35.273B 41.54
DexCom (DXCM) United States $30.978B 46.65
Waters (WAT) United States $22.985B 33.99
STERIS (STE) Ireland $21.603B 24.87
SONOVA HOLDING (SONVY) Switzerland $20.257B 0.00
Hologic (HOLX) United States $17.928B 19.36
Fresenius Medical Care AG KGaA (FMS) Germany $13.368B 13.72
Sysmex ADR (SSMXY) Japan $13.192B 41.37
Globus Medical (GMED) United States $11.424B 28.93
Penumbra (PEN) United States $9.397B 92.04
Masimo (MASI) United States $9.192B 44.48
Teleflex (TFX) United States $9.024B 14.39
Glaukos (GKOS) United States $7.669B 0.00
PROCEPT BioRobotics (PRCT) United States $5.015B 0.00
Integer Holdings (ITGR) United States $4.655B 26.38
Veracyte (VCYT) United States $3.419B 102.61
Inari Medical (NARI) United States $3.051B 0.00
TransMedics (TMDX) United States $2.857B 90.57
LivaNova (LIVN) United Kingdom $2.839B 16.39
Nihon Kohden (NHNKY) Japan $2.480B 18.84
Elekta AB (EKTAY) Sweden $2.209B 19.86
Tandem Diabetes Care (TNDM) United States $2.135B 0.00
Integra LifeSciences Holdings (IART) United States $1.897B 9.91
RxSight (RXST) United States $1.848B 0.00
Alphatec Holdings (ATEC) United States $1.448B 0.00
Pulse Biosciences (PLSE) United States $1.284B 0.00
Artivion (AORT) United States $1.242B 82.28
OPKO Health (OPK) United States $1.044B 0.00
AVANOS MEDICAL, INC (AVNS) United States $0.901B 15.31
Paragon 28 (FNA) United States $0.864B 0.00
ORTHOFIX MEDICAL INC (OFIX) United States $0.738B 0.00
IRadimed (IRMD) United States $0.682B 36.87
Mesa Laboratories (MLAB) United States $0.660B 15.55
AxoGen (AXGN) United States $0.641B 0.00
OrthoPediatrics (KIDS) United States $0.628B 0.00
SiBone (SIBN) United States $0.561B 0.00
Treace Medical Concepts (TMCI) United States $0.547B 0.00
Pacific Biosciences Of California (PACB) United States $0.529B 0.00
Semler Scientific (SMLR) United States $0.503B 29.61
Tactile Systems Technology (TCMD) United States $0.446B 24.14
Delcath Systems (DCTH) United States $0.404B 0.00
CVRx (CVRX) United States $0.377B 0.00
ClearPoint Neuro (CLPT) United States $0.338B 0.00
NeuroPace (NPCE) United States $0.337B 0.00
AngioDynamics (ANGO) United States $0.290B 0.00
Inogen (INGN) United States $0.241B 0.00
Accuray (ARAY) United States $0.216B 0.00
Alpha Tau Medical (DRTS) Israel $0.211B 0.00
Sight Sciences (SGHT) United States $0.204B 0.00
KORU Medical Systems (KRMD) United States $0.182B 0.00
Nevro (NVRO) United States $0.160B 0.00
Atossa Genetics (ATOS) United States $0.160B 0.00
Sensus Healthcare (SRTS) United States $0.140B 15.02
Spectral Diagnostics (EDTXF) Canada $0.116B 0.00
908 Devices (MASS) United States $0.100B 0.00
EDAP TMS S.A (EDAP) France $0.092B 0.00
LENSAR (LNSR) United States $0.088B 0.00
InspireMD (NSPR) Israel $0.080B 0.00
WORK Medical Technology Group (WOK) China $0.079B 0.00
Vicarious Surgical (RBOT) United States $0.074B 0.00
Hyperfine (HYPR) United States $0.073B 0.00
Monogram Orthopaedics (MGRM) United States $0.070B 0.00
Lucid Diagnostics (LUCD) United States $0.058B 0.00
EnVVeno Medical (NVNO) United States $0.056B 0.00
Envoy Medical (COCH) United States $0.046B 0.00
Rapid Micro Biosystems (RPID) United States $0.043B 0.00
Accelerate Diagnostics (AXDX) United States $0.041B 0.00
Spectral AI (MDAI) United States $0.041B 0.00
Adagio Medical Holdings (ADGM) United States $0.036B 0.00
Neuronetics (STIM) United States $0.034B 0.00
Precision Optics (POCI) United States $0.031B 0.00
DarioHealth (DRIO) United States $0.026B 0.00
Biosig Technologies (BSGM) United States $0.026B 0.00
NexGel (NXGL) United States $0.023B 0.00
Inspira Technologies OXY B.H.N (IINN) Israel $0.017B 0.00
Microbot Medical (MBOT) United States $0.017B 0.00
Baird Medical Investment Holdings (BDMD) $0.016B 0.00
Ekso Bionics Holdings (EKSO) United States $0.015B 0.00
Aspira Women's Health (AWH) United States $0.014B 0.00
PAVmed (PAVM) United States $0.012B 0.00
T2 Biosystems (TTOO) United States $0.012B 0.00
QT Imaging Holdings (QTI) United States $0.010B 0.00
Tenon Medical (TNON) United States $0.007B 0.00
Nuwellis (NUWE) United States $0.006B 0.00
SINTX TECHNOLOGIES, INC (SINT) United States $0.005B 0.00
Autonomix Medical (AMIX) United States $0.005B 0.00
Check-Cap (CHEK) Israel $0.005B 0.00
ReShape Lifesciences (RSLS) United States $0.004B 0.00
ENDRA Life Sciences (NDRA) United States $0.003B 0.00
Avinger (AVGR) United States $0.003B 0.00
Nanovibronix (NAOV) United States $0.003B 0.00
Helius Medical Technologies (HSDT) United States $0.002B 0.00
Venus Concept (VERO) Canada $0.002B 0.00
Bluejay Diagnostics (BJDX) United States $0.002B 0.00
Longview Acquisition II (LGV) United States $0.000B 0.00
Spinal Elements Holdings (SPEL) United States $0.000B 0.00